Tuesday, 3 November 2015
Inspirational research showcased at ‘Bridging Bench to Better Medicines’ conference in Cambridge
On the 16th September, 2015 more than 100 scientists from academic and commercial research organisations from across Cambridge and the South East and from AstraZeneca Pharmaceutical Development and MedImmune Biopharmaceutical Development gathered at the Robinson College in Cambridge to discuss science and innovation at the Bridging Bench to Better Medicines (BB2BM) conference.
One of the goals for the conference was to inspire and encourage to the creation of new connections between scientists from AstraZeneca and external partners. BB2BM was a great first step in facilitating these connections and the next step will be to build on these new relationships, develop new collaborations and ensure that new research findings can be translated in to patient benefit.
The feedback received directly from delegates and via the post-event survey was overwhelmingly positive and reinforced the importance of getting people together to meet face to face. The varied agenda of speaker sessions containing short presentations from internal and external speakers alongside posters and networking sessions proved to be the ideal environment to introduce exciting, emerging research from the Cambridge and South East region as well as helping to identify new potential collaboration areas.
What will happen next?
Feedback has indicated that the new connections that were made as a result of the event will lead to the development of new collaborations and research projects. It was clear from the event that the driver to contribute to the development of future medicines which improve the lives of patients was at the forefront of discussions and the framing of BB2BM to bring together scientist from many different facets of development was a catalyst in identifying new ideas and opportunities.
BB2BM was a great first step in facilitating connections. The next step will be to build on these new relationships, develop and refine collaborations and ensure that new research findings can be translated in to patient benefit.
For more information, please contact Emma Woods, Scientific Patent Advisor & Pharmaceutical Development Innovation Lead.
Links to some of the talks from the day: